Amyloid β-Protein (31-35)
A-1439-2 | (Met(O)35)-Amyloid β-Protein (25-35) | C45H81N13O15S | 1076.28 | 292147-12-7 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O)-OH |
A-1439-4 | (Nle35)-Amyloid β-Protein (25-35) | C46H83N13O14 | 1042.24 | 163265-32-5 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-OH |
A-1440 | Amyloid β-Protein (35-25) | C45H81N13O14S | 1060.28 | 147740-73-6 | H-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-OH |
A-1439-3 | Amyloid β-Protein (25-35) amide | C45H82N14O13S | 1059.30 | 147490-49-1 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 |
A-1441 | Amyloid β-Protein (29-40) | C49H88N12O13S | 1085.38 | 184865-04-1 | H-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1442 | Propionyl-Amyloid β-Protein (31-34) amide | C23H43N5O5 | 469.63 | 256419-86-0 | Propionyl-Ile-Ile-Gly-Leu-NH2 |
A-1443 | Amyloid β-Protein (31-35) | C25H47N5O6S | 545.74 | 149385-65-9 | H-Ile-Ile-Gly-Leu-Met-OH |
A-1445-2 | Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid β-Protein (33-40) | C58H99N19O18S2 | 1414.67 | H-Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1445 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40) | C51H93N15O14S2 | 1204.52 | H-Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1446 | Amyloid β-Protein (33-42) Amyloid β/A4 Protein Precursor770 (704-713), APP770 (704-713) |
C41H74N10O11S | 915.17 | 178949-81-0 | H-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1447 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (35-40) | C43H79N13O12S2 | 1034.31 | H-Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val-OH | |
A-1444 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42) | C47H86N14O13S | 1087.35 | H-Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1448 | Non-Aβ Component of Alzheimer's Disease Amyloid NAC |
C141H235N39O49 | 3260.65 | 154040-19-4 | H-Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val-OH |
A-1449 | Amyloid β-Protein (1-14) | C73H99N23O25 | 1698.73 | 186319-74-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-OH |
A-1450 | Amyloid ß-Protein (37-39) | C9H17N3O4 | 231.25 | 20274-89-9 | H-Gly-Gly-Val-OH |
A-1451 | (Leu16)-Amyloid β-Protein (16-19) | C26H42N4O5 | 490.64 | 24205-68-3 | H-Leu-Leu-Val-Phe-OH |
A-1452 | (Nle35)-Amyloid β-Protein (1-42) | C204H313N55O60 | 4496.06 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1453 | Methoxysuccinyl-Amyloid β-Protein (39-42)-p-nitroanilide | C30H46N6O9 | 634.73 | MeOSuc-Val-Val-Ile-Ala-pNA | |
A-1454 | Amyloid β-Protein (38-40) | C9H17N3O4 | 231.25 | 21835-35-8 | H-Val-Gly-Gly-OH |
A-1502 | Angiogenin (108-122) | C78H125N25O23 | 1781.01 | 112173-49-6 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-OH |
A-1503 | Angiogenin (108-123) | C83H132N26O24 | 1878.12 | 112173-48-5 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro-OH |
A-1601 | Angiotensin A Ala-Angiotensin III, (Ala1)-Angiotensin II |
C49H71N13O10 | 1002.18 | 51833-76-2 | H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1602 | Angiotensin I Ang I, Angiotensinogen (1-10) |
C62H89N17O14 | 1296.50 | 484-42-4 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-2 | Acetyl-Angiotensin I | C64H91N17O15 | 1338.53 | 67509-13-1 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-3 | Biotinyl-Angiotensin I | C72H103N19O16S | 1522.79 | Biotinyl-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH | |
A-1602-4 | (Des-Asp1)-Angiotensin I | C58H84N16O11 | 1181.41 | 56317-01-2 | H-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-5 | (Val5,Asn9)-Angiotensin I Angiotensin I (bullfrog) |
C59H86N16O15 | 1259.43 | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | |
A-1603 | Angiotensin I (1-9) | C56H78N16O13 | 1183.34 | 34273-12-6 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-OH |
A-1604 | Angiotensin (1-12) (human) Angiotensinogen (1-12) (human), Proangiotensin-12 (human) |
C73H109N19O16 | 1508.79 | 136865-09-3 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-OH |
A-1604-2 | Angiotensin (1-12) (mouse, rat) Angiotensinogen (1-12) (mouse, rat), Proangiotensin (1-12) (mouse, rat) |
C77H109N19O17 | 1572.83 | 914910-73-9 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-OH |
A-1605 | Angiotensin II, Ang II | C50H71N13O12 | 1046.19 | 4474-91-3 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1605-2 | (p-Amino-Phe6)-Angiotensin II | C53H74N12O12 | 1071.24 | 90937-05-6 | H-Asp-Arg-Val-Tyr-Ile-p-amino-Phe-Pro-Phe-OH |
A-1605-3 | (Asn1,Val5)-Angiotensin II, Angiotensinamide | C49H70N14O11 | 1031.18 | 53-73-6 | H-Asn-Arg-Val-Tyr-Val-His-Pro-Phe-OH |
A-1605-4 | (Des-Asp1,Ile8)-Angiotensin II | C43H68N12O9 | 897.09 | 52498-25-6 | H-Arg-Val-Tyr-Ile-His-Pro-Ile-OH |
A-1605-5 | (3,5-Diiodo-Tyr4)-Angiotensin II | C50H69I2N13O12 | 1297.99 | H-Asp-Arg-Val-3,5-diiodo-Tyr-Ile-His-Pro-Phe-OH | |
A-1605-6 | (Sar1)-Angiotensin II | C49H71N13O10 | 1002.18 | 51833-69-3 | Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1605-7 | (Sar1,Ala8)-Angiotensin II (Ile5)-Saralasin |
C43H67N13O10 | 926.09 | 38027-95-1 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OH |
A-1605-8 | (Sar1,Gly8)-Angiotensin II | C42H65N13O10 | 912.06 | 51887-62-8 | Sar-Arg-Val-Tyr-Ile-His-Pro-Gly-OH |
A-1605-9 | (Sar1,Ile4·8)-Angiotensin II | C43H75N13O9 | 918.15 | 185461-45-4 | Sar-Arg-Val-Ile-Ile-His-Pro-Ile-OH |
A-1605-10 | (Sar1,Ile8)-Angiotensin II Sarilesin |
C46H73N13O10 | 968.17 | 37827-06-8 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ile-OH |
A-1605-11 | (Sar1,Thr8)-Angiotensin II Sarthran |
C44H69N13O11 | 956.11 | 53632-49-8 | Sar-Arg-Val-Tyr-Ile-His-Pro-Thr-OH |
A-1605-12 | (Sar1,Tyr(Me)4)-Angiotensin II Sarmesin |
C50H73N13O10 | 1016.21 | 88874-29-7 | Sar-Arg-Val-Tyr(Me)-Ile-His-Pro-Phe-OH |
A-1605-13 | (Sar1,Val5,Ala8)-Angiotensin II Saralasin |
C42H65N13O10 | 912.06 | 34273-10-4 | Sar-Arg-Val-Tyr-Val-His-Pro-Ala-OH |
A-1605-14 | (Val5)-Angiotensin II | C49H69N13O12 | 1032.17 | 58-49-1 | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-OH |
A-1606 | Angiotensin II Antipeptide | C42H62N10O12 | 899.01 | 121379-63-3 | H-Glu-Gly-Val-Tyr-Val-His-Pro-Val-OH |
A-1607 | Angiotensin II Receptor Ligand CGP42112A, CGP42112 |
C52H69N13O11 | 1052.20 | 127060-75-7 | Nicotinoyl-Tyr-Lys(Z-Arg)-His-Pro-Ile-OH |
A-1608 | Angiotensin I/II (1-5) | C30H48N8O9 | 664.76 | 58442-64-1 | H-Asp-Arg-Val-Tyr-Ile-OH |
A-1609 | Angiotensin I/II (1-6) | C36H55N11O10 | 801.90 | 47896-63-9 | H-Asp-Arg-Val-Tyr-Ile-His-OH |
A-1610 | Angiotensin I/II (1-7) | C41H62N12O11 | 899.02 | 51833-78-4 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH |
A-1610-2 | (D-Ala7)-Angiotensin I/II (1-7) A-779 |
C39H60N12O11 | 872.98 | 159432-28-7 | H-Asp-Arg-Val-Tyr-Ile-His-D-Ala-OH |
A-1610-3 | Biotinyl-Angiotensin I/II (1-7) | C51H76N14O13S | 1125.32 | Biotinyl-Asp-Arg-Val-Tyr-Ile-His-Pro-OH | |
A-1610-4 | (Sar1)-Angiotensin I/II (1-7) amide Angiotensin II antagonist. |
C40H63N13O8 | 854.02 | 126112-22-9 | Sar-Arg-Val-Tyr-Ile-His-Pro-NH2 |
A-1611 | Angiotensin I/II (3-7) | C31H45N7O7 | 627.74 | 122483-84-5 | H-Val-Tyr-Ile-His-Pro-OH |
A-1612 | Angiotensin I/II (3-8) Angiotensin IV |
C40H54N8O8 | 774.92 | 23025-68-5 | H-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1613 | Angiotensin I/II (4-8) | C35H45N7O7 | 675.79 | 52530-60-6 | H-Tyr-Ile-His-Pro-Phe-OH |
A-1614 | Angiotensin I/II (5-8) | C26H36N6O5 | 512.61 | 34233-50-6 | H-Ile-His-Pro-Phe-OH |
A-1615 | Angiotensin III | C46H66N12O9 | 931.11 | 13602-53-4 | H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1615-2 | (Val4)-Angiotensin III | C45H64N12O9 | 917.08 | H-Arg-Val-Tyr-Val-His-Pro-Phe-OH | |
A-1616 | Acetyl-Ang II-Lys | C58H85N15O14 | 1216.42 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-Lys-OH | |
A-1701 | Annexin A1 (1-11) (dephosphorylated) (human, bovine, chicken, porcine) Annexin-1 (2-12) (human, bovine, chicken, porcine), Lipocortin-1 (2-12), Calpactin II (1-11) (dephosphorylated) (human, bovine, chicken, porcine) |
C63H94N14O17S | 1351.59 | 256447-08-2 | Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-OH Trifluoroacetate salt |
A-1702 | Annexin A1 (1-25) (dephosphorylated) (human) Annexin-1 (2-26) (human), Lipocortin-1 (2-26), Calpactin II (1-25) (dephosphorylated) (human), Ac2-26 |
C141H210N32O44S | 3089.47 | 151988-33-9 | Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys-OH Trifluoroacetate salt |
A-1801 | Biotinyl-5-aminopentanoyl-Antennapedia Homeobox (43-58) amide Biotinyl-5-aminopentanoyl-Antennapedia Homeobox Protein (43-58) amide (Drosophila melanogaster), Biotinyl-5-aminopentanoyl-Antp Homeobox (43-58) amide |
C119H192N38O22S2 | 2571.21 | 179764-32-0 | Biotinyl-5-aminopentanoyl-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-NH2 Trifluoroacetate salt |
A-1802 | Cys(NPys)-Antennapedia Homeobox (43-58) amide Cys(NPys)-Antennapedia Homeobox Protein (43-58) amide (Drosophila melanogaster), Cys(NPys)-Antp Homeobox (43-58) amide |
C112H176N38O22S3 | 2503.07 | 220337-24-6 | H-Cys(NPys)-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-NH2 Trifluoroacetate salt |
A-1803 | (Cys-Antennapedia Homeobox (43-58) amide)-(Cys-FLAG-Cofilin (1-13) (human, mouse, porcine, rat)) (Cys-Antp Homeobox (43-58) amide)-(Cys-FLAG-P18 (1-13) (human, mouse, porcine, rat)) |
C203H327N61O58S4 | 4678.47 | (H-Cys-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-NH2)A(H-Cys-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-Met-Ala-Ser-Gly-Val-Ala-Val-Ser-Asp-Gly-Val-Ile-Lys-OH)B (Disulfide bond between Cys¹A and Cys¹B) Trifluoroacetate salt |
|
A-1804 | FITC-εAhx-Antennapedia Homeobox (43-58) amide FITC-εAhx-Antennapedia Homeobox Protein (43-58) amide (Drosophila melanogaster), FITC-εAhx-Antp Homeobox (43-58) amide |
C131H191N37O25S2 | 2748.32 | FITC-εAhx-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-NH2 Trifluoroacetate salt |
|
A-1901 | Anthopleurin-A | C220H326N64O67S6 | 5131.80 | 60880-63-9 | H-Gly-Val-Ser-Cys-Leu-Cys-Asp-Ser-Asp-Gly-Pro-Ser-Val-Arg-Gly-Asn-Thr-Leu-Ser-Gly-Thr-Leu-Trp-Leu-Tyr-Pro-Ser-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Lys-Ala-His-Gly-Pro-Thr-Ile-Gly-Trp-Cys-Cys-Lys-Gln-OH (Disulfide bonds between Cys4 and Cys46/Cys6 and Cys36/Cys29 and Cys47) |
A-1902 | Antho-Rfamide | C22H32N8O5 | 488.55 | 107535-01-3 | Pyr-Gly-Arg-Phe-NH2 |
A-1903 | Antho-Rnamide | C25H40N8O6 · HCl | 585.10 | 129536-35-2 | L-β-Phenyllactoyl-Leu-Arg-Asn-NH2 · HCl |
A-1904 | Antho-RPamide I | C45H75N13O9 · 2 HCl | 1015.09 | 145523-59-7 | H-Leu-Pro-Pro-Gly-Pro-Leu-Pro-Arg-Pro-NH2 · 2 HCl |
A-1905 | Antho-RPamide II | C41H60N14O9 · HCl | 929.48 | 352280-38-7 | Pyr-Asn-Phe-His-Leu-Arg-Pro-NH2 · HCl |
合肥赛曼诺生物科技有限公司是专注于固相合成方法学研究的专业化高科技公司。赛曼诺具有多年的固相合成研究开发生产经验。赛曼诺致力于为全球范围内的客户提供包括肽核酸,类肽和多肽定制合成服务以及肽核酸单体,类肽单体。其中肽核酸(单体)和类肽(单体)填补了国内市场的空白,使国内的用户可以摆脱对进口试剂的依赖。赛曼诺建立了先进的研发中心,并且配备了固相合成、冻干和纯化一整套的分析检测仪器。从原料采购、生产过程到成品入库各个环节对产品的质量进行严重控制。针对每一批次的产品从合成记录、纯化方法、检测报告都有详细的记录。应用Fmoc-固相合成方法,通过HPLC高效液相色谱纯化的方式,以低廉的价格,优质的产品,完善的服务来满足客户对研发成本和周期的要求。赛曼诺生物在提供给客户最优惠价格的同时,,产品质量和交货期也得到国内外客户的认可。而且赛曼诺对近2000多种常用目录多肽正在逐步建立和完善库存,将来能极大的缩短客户的研发周期以节约成本。赛曼诺生物可以提供从毫克到百克级肽核酸,类肽和多肽等相关产品的定制合成服务,以及不同纯度等级的产品来满足不同客户对不同研发项目的需求。
单位名称: |
详细地址:
合肥市高新区望江西路与科学大道交叉口驰远创业园
|
qq:
1761863581
|
联系电话: |
Email: |